Pacer Advisors
NVO

Pacer Advisors’s Novo Nordisk NVO Stock Holding History

Pacer Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28,277
Closed -$1.96M – 3539
2025
Q1 		$1.96M Buy
28,277
+1,387
+5% +$115K ﹤0.01% 974
2024
Q4 		$2.31M Buy
26,890
+44
+0.2% +$4.76K 0.01% 911
2024
Q3 		$3.2M Sell
26,846
-1,295
-5% -$173K 0.01% 784
2024
Q2 		$4.02M Sell
28,141
-885
-3% -$117K 0.01% 655
2024
Q1 		$3.73M Sell
29,026
-680
-2% -$80.9K 0.01% 664
2023
Q4 		$3.07M Buy
29,706
+14,702
+98% +$1.45M 0.01% 680
2023
Q3 		$1.36M Sell
15,004
-12,060
-45% -$1.06M 0.01% 716
2023
Q2 		$2.19M Buy
27,064
+1,636
+6% +$134K 0.01% 703
2023
Q1 		$2.02M Buy
25,428
+816
+3% +$57.9K 0.01% 718
2022
Q4 		$1.67M Buy
+24,612
New +$1.44M 0.01% 607
2022
Q1 		– Sell
-25,352
Closed -$1.42M – 2471
2021
Q4 		$1.42M Sell
25,352
-798
-3% -$43.2K 0.01% 1001
2021
Q3 		$1.25M Buy
26,150
+816
+3% +$39.4K 0.02% 794
2021
Q2 		$1.06M Sell
25,334
-200
-0.8% -$7.75K 0.02% 822
2021
Q1 		$861K Sell
25,534
-1,370
-5% -$48.8K 0.02% 838
2020
Q4 		$940K Sell
26,904
-6,028
-18% -$208K 0.02% 728
2020
Q3 		$1.14M Buy
+32,932
New +$1.1M 0.02% 646
2020
Q1 		– Sell
-25,200
Closed -$729K – 967
2019
Q4 		$729K Buy
25,200
+7,020
+39% +$194K 0.03% 653
2019
Q3 		$470K Buy
18,180
+5,740
+46% +$145K 0.01% 1005
2019
Q2 		$317K Buy
+12,440
New +$307K 0.01% 1022
2017
Q4 		– Sell
-2,324
Closed -$56K – 1256
2017
Q3 		$56K Buy
+2,324
New +$52.5K 0.01% 1100
2013
Q4 		$311K Buy
+73,500
New +$1.28M 0.07% 352

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Pacer Advisors's NVO Position: Q2 2025 in Review

Pacer Advisors sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 28,277 shares — an estimated $1.96M sold.

Pacer Advisors first reported a position in NVO in Q4 2013 and held it in 21 quarters. The position peaked at $4.02M in Q2 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Pacer Advisors reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Pacer Advisors sold 28,277 Novo Nordisk shares in Q2 2025, an estimated $1.96M.
  • Pacer Advisors first reported a position in Novo Nordisk in Q4 2013 and held it in 21 quarters.
  • Pacer Advisors's Novo Nordisk position peaked at $4.02M in Q2 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Pacer Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.